eFFECTOR’s Zotatifin (eFT226) Downregulates Key Oncogenic Driver Proteins Including RTKs
SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
- Oct 21, 2020
Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Public Oncology Leader
Leading institutional investors commit $500 million through concurrent equity investments Upon completion of the business combination,...
- Oct 14, 2020
First Companies Commit to Purchasing Verified Agricultural Carbon Credits through Indigo Carbon
Boston Consulting Group, Shopify, Barclays, JPMorgan Chase, Givewith, IBM, Dogfish Head Craft Brewery, and New Belgium Brewing commit to...
- Oct 14, 2020
Pacemaker Pair Keeps Monique in Sync -- EBR Systems
A pair of revolutionary leadless pacemakers have been successfully implanted into the heart of a patient in Melbourne in a world-first...
- Oct 6, 2020
Federation Bio goes live with $50M to pursue microbial treatments
Several companies are exploring microbiome treatments for various ailments, ranging from Parkinson’s disease and multiple sclerosis to...
bottom of page